The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Injury and ...

Conclusion: Administration of calcitriol in patients with non-ST-segment elevation acute coronary syndromes undergoing elective PCI can attenuate the increase in serum inflammatory biomarkers in the serum (hs-CRP and hs-IL-6) and thus decrease the inflammatory reaction caused by PCI.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research